Brand profile · Biotechnology Research

NeuroVanda Therapeutics

NeuroVanda Therapeutics runs a Biotechnology Research operation from Singapore. The record marks it privately held. It holds one address on record, all in Singapore. Headcount on record is 7. One Singapore registration (UEN) is a confirmed match. The record links seven similar brands, most of them in Biotechnology Research.

LinkedIn

Profile live Privately Held 1 entity UEN 1 office country
Registry verified · ACRA
Counted staff
7
self-reported 2–10 band
Founded
Not recorded
Legal entities
1
ACRA
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

Legal entities

NeuroVanda Therapeutics: 1 registry entityNeuroVanda Therapeutics is linked to 1 registry entity: NEUROVANDA THERAPEUTICS PTE. LTD. (UEN 202341984E, confirmed).NeuroVanda TherapeuticsNEUROVANDATHERAPEUTICS PTE. LTD.UEN 202341984EConfirmed · ACRA
Show as table
NEUROVANDA THERAPEUTICS PTE. LTD.UEN 202341984E
Confirmed matches1 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

NeuroVanda is a Singapore-based biotech developing transformational therapies for neurodegenerative diseases. We achieve this by leveraging deep insights in disease mechanism, employing disease-relevant models and pairing the best-suited therapeutic modalities with the most pertinent targets

Our team consists of world-renowned scientific founders from the University of Pennsylvania, Weill Cornell Medical Colleague and University of California, San Francisco. NeuroVanda leverages translational models that have been developed over decades in the labs of our scientific founders and are guided by deep expertise to further establish pathophysiologically relevant models. The NeuroVanda team comprises experienced drug hunters who have deep expertise in developing novel modalities such as protein degraders to tackle the most pertinent targets.

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary SG. Codes: SG.1 countryprimary SGSG
Show as table
Countries1
Primary countrySG

All codes: SG

Addresses

  • SG1 N Buona Vista Link; Singapore, 139691Primary

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Notify me about spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend
Notify me about signals

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
Notify me about financials

People & contacts

4 employee profiles on record · names withheld.

Names are withheld until a consented source exists.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under NeuroVanda Therapeutics?

One Singapore entity on ACRA: NEUROVANDA THERAPEUTICS PTE. LTD. (UEN 202341984E), high confidence.

How many people work at NeuroVanda Therapeutics?

7 counted staff profiles at January 2026, inside the self-reported 2–10 band.

Where does NeuroVanda Therapeutics have offices?

One address on record, Singapore only. Primary: 1 N Buona Vista Link, Singapore 139691.

Has NeuroVanda Therapeutics raised funding?

None linked to this brand.

Which companies are listed alongside NeuroVanda Therapeutics?

7 profiles list NeuroVanda Therapeutics as a peer — 73rd percentile in Biotechnology Research. It lists ten peers of its own. Trinity Innovation Bioventure Singapore and Ligature Therapeutics list it back.